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ABSTRACT
Objective: Pain is one of the most common reasons for an individual to consult their primary care
physician, with most chronic pain being treated in the primary care setting. However, many primary
care physicians/non-pain medicine specialists lack enough awareness, education and skills to manage
pain patients appropriately, and there is currently no clear, common consensus/formal definition of
“pain chronification”.
Methods: This article, based on an international Change Pain Chronic Advisory Board meeting which
was held in Wiesbaden, Germany, in October 2016, provides primary care physicians/non-pain medi-
cine specialists with a narrative overview of pain chronification, including underlying physiological and
psychosocial processes, predictive factors for pain chronification, a brief summary of preventive strat-
egies, and the role of primary care physicians and non-pain medicine specialists in the holistic manage-
ment of pain chronification.
Results: Based on currently available evidence, we propose the following consensus-based definition
of pain chronification which provides a common framework to raise awareness among non-pain medi-
cine specialists: “Pain chronification describes the process of transient pain progressing into persistent
pain; pain processing changes as a result of an imbalance between pain amplification and pain inhib-
ition; genetic, environmental and biopsychosocial factors determine the risk, the degree, and time-
course of chronification.”
Conclusions: Early intervention plays an important role in preventing pain chronification and, as key
influencers in the management of patients with acute pain, it is critical that primary care physicians
are equipped with the necessary awareness, education and skills to manage pain patients
appropriately.
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Pain is one of the most common reasons for an individual to
consult their primary care physician1–3, with one in five
adults in Europe estimated to be affected by chronic pain4.
However, one of the challenges of managing pain in the pri-
mary care setting is that it is poorly assessed and reported5–9.
Chronic pain has a major negative impact on quality of life,
workforce participation and productivity, and healthcare
expenditure4,10–15. Indeed, US statistics estimate that total
annual costs associated with chronic pain are $US560–635
billion16 whereas, across Europe, data indicate that 3–10% of
gross domestic product is spent on national healthcare and
socioeconomic costs associated with chronic pain17,18.
Pain has been defined by various groups over the years,
often categorized according to the terms “acute” and
“chronic”19–21. A common definition of acute pain is “the nor-
mal, predicted physiological response to an adverse chemical,
thermal or mechanical stimulus… associated with surgery,
trauma, and acute illness”19. Traditionally, chronic pain has
been defined by the International Association for the Study
of Pain (IASP) as “pain without apparent biological value that
has persisted beyond the normal tissue healing time (usually
about 3 months)”22. It is widely accepted that, unlike acute
pain, chronic pain has no protective function20. Recently, an
updated definition of pain has been proposed: “Pain is a dis-
tressing experience associated with actual or potential tissue
damage with sensory, emotional, cognitive, and social
components”23.
However, the conventional temporal definitions don’t
account for the complex mechanistic distinctions between
acute (physiological) and chronic (pathological) pain and the
transition from acute to chronic pain states20,24. Indeed, the
term “chronic” is derived from “chronos” (Greek) which only
indicates the temporal but not the mechanistic aspects,
something which is inferred by many physicians but isn’t
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part of the specific definition. Furthermore, conventional defi-
nitions do not account for the course of pain over time (pain
trajectories) associated with different pain types25. Evaluating
pain trajectories could better describe the course of pain,
and the predictors of that course, potentially resulting in the
elucidation of the beginnings of common long-term pain
conditions25,26.
A 2011 Institute of Medicine (IOM) report states that “we
believe it is necessary to understand better the link between
acute and chronic pain and find ways to break that link”27.
This article is based on a Change Pain Chronic Advisory
Board meeting, consisting of pain specialists from Europe
and the US, which was held in Wiesbaden, Germany, in
October 2016. The objective of this article is to provide an
updated overview of pain chronification, including underlying
physiological and psychosocial processes and predictive fac-
tors for pain chronification, and the role of non-pain medi-
cine specialists in the holistic management of pain
chronification, and to propose a consensus-based definition
of pain chronification.
Pain chronification: what is it?
From the mid-1990s, terms such as “chronicity”, “persistent
pain” and “pain chronification” started to appear in the litera-
ture28–30. Over time, the terms have been used in various ways
in the literature relating to pain conditions. However, there is
a need for common semantics, and an urgent requirement for
an internationally accepted framework and terminology.
Currently, there are cultural/linguistic differences in the
interpretation of the word “chronification”. For example, in
Germany the term “pain chronification” includes chronic pain
as the end point of the process, whereas others consider
“pain chronification” to describe only the transition process
from acute pain to chronic pain. Moreover, some languages
(e.g. British English) do not yet recognize “chronification” as a
real word31.
As part of the Change Pain Chronic Advisory Board meet-
ing of pain specialists, attendees generated and reached con-
sensus agreement on the following overarching definition of
“pain chronification”:
 Pain chronification describes the process of transient pain
progressing into persistent pain.
 Pain processing changes as a result of an imbalance
between pain amplification and pain inhibition.
 Genetic, environmental and biopsychosocial factors deter-
mine the risk, degree and time-course of chronification.
The following sections discuss aspects of the scientific
rationale which support this proposed definition of pain
chronification.
Biological and psychosocial processes involved in
pain chronification
The biopsychosocial model is now widely accepted as the
most heuristic approach to the development and
maintenance of chronic pain32–34. In addition to neurobio-
logical processes, the overall biopsychosocial model encom-
passes research on psychological and social factors which
can interact with brain processes to influence an individual’s
well-being32. Using the biopsychosocial approach, pain and
disability can be described as a multidimensional, dynamic
interplay of physiological, psychological and social factors
that influence each other in a reciprocal manner, leading to
chronic and complex pain syndromes33.
From the physiological perspective, the standard classifica-
tion of pain differentiates between nociceptive pain, which
originates in tissues in response to a nociceptor stimulation
or nociceptive stimulus, and neuropathic pain, which origi-
nates in the peripheral or central nervous system (CNS) as a
result of nerve fiber damage or inflammation. In both cases,
neurotransmitters (e.g. glutamate [excitatory effect, enhances
pain] and gamma-aminobutyric acid [GABA; inhibitory effect,
reduces pain]) transfer nociceptive impulses via neurons to
the spinal cord which are then passed to the brain stem via
ascending pathways where they are interpreted within higher
centers35–38. Descending pathways simultaneously modify
pain perception via the noradrenergic pain regulation sys-
tem37,39. Details of the noxious stimuli are transmitted from
the limbic system and midbrain structures down through the
periaqueductal grey to the brainstem, in particular the rostro-
ventromedial medulla, where the signals are filtered before
transferring to the spinal cord dorsal horn at the level of the
incoming pain signal40. Noradrenaline, which reduces pain,
and serotonin (or 5-hydroxytryptamine), which may have
both facilitatory and inhibitory functions, are important neu-
rotransmitters in the descending modulatory pathways41–43.
Although further research is required, there is some promise
that it might be possible to measure these modulatory sys-
tems clinically and reliably by conditioned pain modula-
tion (CPM)44.
The development and maintenance of many chronic pain
syndromes appears to arise from an imbalance between
amplified ascending signals and inadequate activation of the
descending inhibitory pathway (Figure 1)45. Normally, a
robust descending inhibitory system may be engaged to pro-
tect against the development of chronic pain and recent clin-
ical findings indicate that diminished descending inhibition is
potentially an important factor in determining whether acute
pain becomes chronic40,46,47. Indeed, when exposed to
inflammatory mediators and growth factors in response to
activity and after injury, the nociceptive system is capable of
undergoing significant changes or plasticity42,48.
Peripheral and central sensitization
Peripheral or central sensitization may result in increased
nociceptive input to the brain and can also change the proc-
essing of nociceptive information within the brain48–50. As a
result of inflammation or lesion, alterations in the nociceptive
system occur in nociceptors, with their peripheral terminals
becoming sensitized (peripheral sensitization). This process is
characterized by hyperexcitability and an increased sensitivity
to chemical, thermal and mechanical stimuli and
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spontaneous activity of the neuron. Indeed, axons can also
become sufficiently hyperexcitable to generate spontaneous
action potentials, cell bodies can undergo dramatic altera-
tions in protein expression and trafficking, and changes can
occur in the strength and structural organization of spinal
cord synapses. Similar functional and structural changes take
place in the spinal cord and brain, involving central neurons
and non-neuronal cells (e.g. glial cells51), and these changes
(central sensitization) are responsible for facilitating the
responses to peripheral inputs so that the threshold for gen-
erating pain decreases and the duration, amplitude and spa-
tial distribution of pain increase52,53. Clinically, innocuous
tactile stimuli can become painful (allodynia) or nociceptive
stimuli can evoke more intense painful sensations
(hyperalgesia).
Due to the fact that central sensitization results from
changes in the properties of neurons in the CNS, pain associ-
ated with the chronification process is no longer linked, as in
acute nociceptive pain, to the presence, intensity or duration
of noxious peripheral stimuli. On the contrary, central sensi-
tization produces pain hypersensitivity by changing the sen-
sory response elicited by normal inputs, including inputs that
usually evoke innocuous sensations52.
Multiple mechanisms contribute to these changes, with
each one being subject to, or an expression of, neural
plasticity (the capacity of neurons to change their function,
chemical profile, or structure)54. In some pain syndromes,
such as fibromyalgia and irritable bowel syndrome, no identi-
fiable noxious stimulus nor lesion or disease of the somato-
sensory nervous system is present. Some authors classify
these pain syndromes under the term central sensitivity syn-
dromes, indicating the presence of central sensitization as
the predominant mechanism55,56.
Functional and structural neuroplasticity
Increasing evidence reveals structural and functional mal-
adaptive neuroplastic changes within the central and periph-
eral nervous system of individuals with chronic pain
disorders that appear to play a prominent role in the patho-
physiology of these disorders48,57,58.
Molecules may become functionally sensitized, synaptic
transmission may become potentiated by presynaptic mecha-
nisms or by postsynaptic plasticity, cells may respond to nox-
ious stimuli with increased activity and expanded receptive
fields after injury and network function may change so that
more cell ensembles respond to noxious stimuli, collectively
leading to a higher net spinal output after injury or
inflammation54.
Figure 1. From the physiological perspective, an imbalance between enhanced ascending nociceptive inputs and inadequate inhibitory descending pathways is
responsible for pain chronification45. Reproduced with permission from Coluzzi et al.45.
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Among the structural changes, synaptic spines may
increase in size and density, axons may sprout or degenerate,
and cells may atrophy (e.g. loss of inhibitory interneurons) or
proliferate (e.g. microglia and astrocytes)54. For example, gray
matter density was reduced in the bilateral dorsolateral pre-
frontal cortex and right thalamus of patients with chronic
back pain, and this reduction was strongly correlated with
pain characteristics59. These findings imply that chronic back
pain is accompanied by brain atrophy and suggest that the
pathophysiology of chronic pain includes thalamocortical
processes59. A subsequent study has shown that chronic low
back pain is associated with decreased cortical thickness in
multiple brain areas and abnormal cognitive task-related
activity; moreover, effective treatment resulted in increased
cortical thickness in the left dorsolateral prefrontal cortex60.
Recent advances in the neuroimaging, electrophysiological
and genetic aspects of neuroplasticity have also demon-
strated the key role that brain atrophy/reduced brain gray
matter volumes play in a range of chronic pain conditions61,
including fibromyalgia62, pelvic pain (CPP)63 and common
forms of chronic headaches64. Women with or without endo-
metriosis-associated CPP displayed decreased gray matter
volume in brain regions involved in pain perception63; in
contrast, increased periaqueductal gray matter volume was
observed in women with endometriosis who had no CPP,
indicating a possible protective role of the descending inhibi-
tory system in these indivivduals63.
In the peripheral nervous system, maladaptive neuroplas-
tic changes have been demonstrated in, for example, the
expression of new receptors (e.g. embryonal Nav 1.8) after
nerve injury. Dysfunction of C-fibers is assumed to underlie
negative symptoms in neuropathic pain and is accompanied
by long-lasting downregulation of Nav 1.8 sodium channel
and m-opioid receptors in the dorsal root ganglion65. Nerve
injury has been shown to upregulate the expression of neu-
ron-restrictive silencer factor in dorsal root ganglion neurons,
mediated through epigenetic mechanisms, suggesting that
this gene silencer causes pathological and pharmacological
dysfunction of C-fibers, which underlies the negative symp-
toms in neuropathic pain65.
In a mouse model of a painful arthritic joint, ectopic
sprouting of sensory and sympathetic nerve fibers was
shown to occur in the painful arthritic joint, indicating that
they may be involved in the generation and maintenance of
arthritic pain66. It has also been postulated that a distinct
subgroup of individuals with osteoarthritis experience wide-
spread pain with neuropathic features67. Sustained pain refer-
ral in these patients is considered to be mediated by central
sensitization, resulting from nociceptors continuously firing
(ectopically) in and around the affected joint67, indicating the
potential for widespread, disproportionate and neuroana-
tomically illogical pain in these patients.
Psychosocial aspects of pain chronification
In patients with subacute back pain, the persistence of
chronic pain was shown to be predetermined by corticolim-
bic neuroanatomical factors68,69. Indeed, the chronification of
back pain shifts brain representation from nociceptive to
emotional learning circuits. Brain representation for a con-
stant percept, back pain, can undergo large-scale shifts in
brain activity with the transition to chronic pain. These obser-
vations challenge long-standing theoretical concepts regard-
ing brain and mind relationships, in addition to providing
important novel insights regarding definitions and mecha-
nisms of chronic pain70,71. This shift from nociceptive to emo-
tional circuits help to provide an underlying explanation for
the psychosocial mechanisms involved in pain chronification.
There is also increasing recognition that many, if not
most, common chronic pain conditions are heterogeneous
with a high degree of overlap, or coprevalence, with other
common pain conditions, along with influences from biopsy-
chosocial factors72. The likely determinants that contribute to
the risk of onset and maintenance of common chronic over-
lapping pain conditions (COPCs) are highlighted in Figure 2.
Consequently, it is important to acknowledge that, rather
than being considered simply as secondary reactions to per-
sistent pain, psychosocial factors play a key role and are intri-
cately involved in a complex mixture of overall
biopsychosocial processes that characterize chronic pain. In
this regard, it is also important to consider lifespan – ideally,
whilst taking into account developmental, biological, psycho-
logical and socioenvironmental aging changes, pain chronifi-
cation taxonomy would apply to individuals of all ages rather
than considering pediatric, adult and geriatric populations
separately73.
Factors which can influence pain chronification
Table 1 summarizes some of the key factors which may influ-
ence the pain chronification process. The timing (i.e. starting
very early) of the various processes and factors which can
contribute to pain chronification require rapid diagnostic
identification and adequate pain management. Therefore, pri-
mary care physicians and other non-pain medicine specialists
have a crucial role to play in avoiding diagnostic and thera-
peutic delays.
Predictive factors associated with pain chronification
include patient demographics (e.g. level of education, female
gender, older age, poor health status)74–79, epigenetics
(phenotypic trait variations which result from developmental
or environmental cues rather than from alterations to the
genomic DNA sequence itself)80–82, acute pain characteristics
(e.g. acute pain intensity/severity, duration, cumulative
trauma exposure) and psychosocial factors (e.g. high baseline
fear, anxiety, negative beliefs on chronic pain severity,
depression, catastrophizing, pain vulnerability/
resilience)33,83,84.
With regard to acute pain characteristics, an analysis of
data from 254 patients receiving total hip replacement and
239 patients receiving total knee replacement in a US cohort
study suggested that, although preoperative widespread
pressure pain sensitivity was associated with pain severity
before and after joint replacement, it was not a predictor of
the amount of pain relief that patients gain from joint
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replacement surgery, independent of preoperative
pain severity85.
As noted previously, psychosocial factors play a crucial
role in the diagnosis and trajectory of chronic pain.
Psychosocial factors can include general variables such as
negative affect, social support and childhood trauma, in add-
ition to variables which are pain-specific, including pain-
related catastrophizing and/or coping, and self-efficacy for
managing pain33. A model based on literature relating to the
progression of acute neck and back pain to chronic pain and
disability showed that greater exposure to past traumatic life
events and depressed mood were most predictive of chronic
pain; depressed mood and negative pain beliefs were most
predictive of chronic disability83. More cumulative traumatic
life events, higher levels of depression in the early stages of
a new pain episode, and early beliefs that pain may be per-
manent, all contribute significantly to increased severity of
subsequent pain and disability83. Borsook and colleagues86
recently proposed the Combined Reward deficiency and
Anti-reward Model (CReAM) to describe how biopsychosocial
variables which modulate brain reward, motivation and stress
functions can interact in a “downward spiral” fashion to
exacerbate the intensity, chronicity and comorbidities of
chronic pain syndromes (i.e. pain chronification).
From the psychosocial perspective, the development of
chronic pain is considered to represent a complex interplay
of multiple factors which represents a balance between vul-
nerability and resilience to pain87,88. Research in this area is
currently limited but it is anticipated that an improved
understanding of the balance between pain vulnerability and
resilience may help to identify at-risk individuals and may
lead to the development of novel therapeutic options which
target new pathways.
Figure 2. This model depicts likely determinants that contribute to the risk of onset and maintenance of common chronic overlapping pain conditions (CPPCs).
These factors are determined by genetic variability and environmental events that determine an individual’s psychological profile and pain amplification status.
These two primary domains are interactive and influence the risk of pain onset and persistence. Likely modifiers of the interaction between genetic and environ-
mental factors include sex and ethnicity72. Abbreviations. MAO, monoamine oxidase; GAD65, glutamate decarboxylase; NMDA, N-methyl-D-aspartic acid; CREB1,
CAMP responsive element binding protein 1; GR, glucocorticoid receptor; CACNA1A, calcium voltage-gated channel subunit alpha1A; POMC, proopiomelanocortin;
NET, norepinephrine transporter; BDNF, brain-derived neurotrophic factor; NGF, nerve growth factor; IKK, IkB kinase; COMT, catechol-O-methyl transferase.
Table 1. Main factors influencing the pain chronification process.
Positive factors Negative factors
Social support (marriage/family) Poor health status
High level of education Type (e.g. neuropathic)
and severity of pain
Coping strategies Depression
Work satisfaction Stress
Appropriate communication with HCPs Litigation
Adequate self-recognition Fear avoidance
Perceived injustice
Catastrophizing
Abbreviation. HCPs, health care professionals.
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Pain chronification: options for its
prevention/management
Any painful condition can lead to the chronification of pain.
It is particularly common with trauma, low back pain and
osteoarthritis. Consequently, treatment options need to be
tailored according to the individual patient and their specific
conditions. This section aims to briefly overview the general
approach to the prevention and management of pain
chronification.
Patient management should follow a logical process
which can be outlined broadly as:
 initial patient assessment (history, examination)
 immediate (preventative) treatment (reassurance, non-
pharmacological and/or pharmacological interventions)
 early treatment (days to weeks), which should aim to
build on previous management options and should con-
sider psychosocial factors/interventions)
 late treatment (weeks to months).
Monotherapy often leads to insufficient therapeutic
response; hence, wherever possible, it is important to identify
the distinct factors causing acute pain and treat them prop-
erly via a multimodal therapeutic approach89,90. If possible,
all acute post-operative pain should be prevented or, at the
very least, diagnosed accurately and then treated promptly
and effectively to improve patient comfort, avoid complica-
tions and reduce the economic burden on society91,92. Based
on a 2013 Cochrane review, the available evidence for
pharmacological prevention of chronic pain is limited and
additional evidence from well designed, large-scale trials is
required in order to rigorously evaluate pharmacological
interventions for the prevention of chronic pain after surgery
in adults93.
Acknowledging the multidimensional factors which can
contribute to the development of chronic pain, M€uller-
Schwefe and colleagues recently highlighted the need to
change the focus of treatment for chronic low back pain to
individually tailored multimodal management (i.e. integrated
multidisciplinary therapy with coordinated somatic and psy-
chotherapeutic options) that reflects the underlying pain
mechanisms94. A multimodal approach for chronic low back
pain may potentially include the use of pharmacotherapy
(including nonsteroidal anti-inflammatory drugs, cyclooxyge-
nase-2 inhibitors, tricyclic antidepressants, opioids and
anticonvulsants)95, in combination with appropriate non-
pharmacological options (including exercise programs,
manual therapies, behavioral therapies, interventional pain
management, physical therapies and traction), and recogniz-
ing that, in carefully selected individuals, surgery may be an
appropriate option94. This comprehensive, multidisciplinary
team-driven approach to the prevention or management of
chronic pain, involving all stakeholders, has been endorsed
elsewhere; however, despite acknowledgement that compre-
hensive multidisciplinary management based on the biopsy-
chosocial model of pain has been shown to be clinically
effective and cost-efficient, it is still not available widely96.
Importantly, with ongoing pain, the role of the peripheral
neuroanatomical structures becomes less important and
more central mechanisms will take over gradually. Therefore,
the focus for management strategies should be directed
more towards the CNS50. Future directions in the manage-
ment of pain chronification include the development of
novel pharmacological interventions in the epigenetic proc-
esses which are involved in chronic pain, stem cell research
and improved diagnoses in patients (e.g. via imaging meth-
ods of peripheral nociceptors)97,98.
The role of non-pain medicine specialists in the
multidisciplinary management of pain
chronification
The majority of chronic pain is treated in the primary care
setting5–9. Unfortunately, as is the case with the majority of
clinicians, primary care physicians and non-pain medicine
specialists are time-poor and confronted with a wide variety
of complex acute and chronic pain conditions that rival the
complexity of those seen in specialized tertiary care pain
management facilities99. In general practice, management
can encompass causal and symptomatic therapy in addition
to the identification of patients who require specialist treat-
ment. Therefore, general practitioners have a key role to play
in the prevention of pain chronification and in the continu-
ation of processes that have been initiated in pain manage-
ment programs.
However, in order for primary care physicians and other
non-pain medicine specialists to play a key role in the pre-
vention of pain chronification, there needs to be awareness
of the problem (i.e. that acute pain can become chronic),
and simple, interdisciplinary education regarding pain man-
agement (including pain chronification)89. There is also an
ethical imperative to orient students, the public, medical care
providers and mental health professionals to the important
role of psychological factors in the experience of pain100. In
addition to improving pain education and awareness for pri-
mary care physicians, pain education is also needed at all lev-
els of psychology training100.
Moreover, few primary care physicians and non-pain medi-
cine specialists are formally trained in effectively managing
pain3,89, and there is considerable scope for improvements in
healthcare literacy relating to the pain chronification process.
Surveys have demonstrated that many physicians do not feel
comfortable managing patients with chronic pain6,101–103.
A large UK survey demonstrated a diversity of attitudes and
self-reported practice behaviors among primary care practi-
tioners (GPs and physiotherapists) with regard to patients
with nonspecific lower back pain104. Education is a key com-
fort factor among primary care physicians and non-pain
medicine specialists, and education/pain management train-
ing has been shown to increase primary care physicians’
comfort in managing patients with chronic pain101.
Although there is a need to assess and address the con-
tinuum of pain, there is currently a lack of awareness and
clarity for primary care physicians to assist them in clearly
understanding the warning signs and non-resolving
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functions, and when to address the situation (e.g. after 2
weeks of unsuccessful therapy, or over a shorter or longer
time period?). The use of properly administered early inter-
ventions, including cognitive–behavioral therapy, potentially
decreases sick leave and prevents chronic problems in
patients with acute pain105,106. Moreover, since psychological
factors are central in the development of chronic problems,
the early administration of a cognitive–behavioral interven-
tion which focuses on the psychological aspects of pain
appears to be feasible for identifying high-risk patients107.
Another recent example of a predictive approach has been
proposed for the management of persistent pain after breast
cancer surgery, using validated prediction models and an
online risk calculator to provide clinicians with a simple tool
to identify patients at high risk of developing persistent pain
and preventive interventions108. However, despite this prom-
ising research and that of others, including the development
of a validated tool to predict the risk of chronic disease in
patients with acute low back pain in an orthopedic practice
setting109,110, there are currently no simple, easy-to-use, evi-
dence-based assessment tools/questionnaires for primary
care physicians, specifically relating to the transition from
acute to chronic pain. It is anticipated that the availability of
such a tool would allow non-pain medicine specialists to
readily identify patients at risk of pain chronification, to bet-
ter understand when to refer to a pain specialist, what to do
in the case of persistent pain, distress, disability and comor-
bidities, and to help identify risk factors/predictors which can
influence the pain chronification process. This represents an
unmet need in the management of pain chronification in the
primary care setting.
A simple, easy-to-use screening tool for neuropathic pain
and localized neuropathic pain, designed for use in general
practice, has previously been shown to have realistic diag-
nostic accuracy111. The screening tool, based on IASP criteria,
focuses on medical history and the distribution of painful
symptoms and sensory signs111. Using currently available
information, is it feasible that a simple, easy-to-use screening
tool could also be developed for use by primary care physi-
cians and non-pain medicine specialists in patients at risk for
pain chronification?
Conclusions
Although there are many good reviews of acute and chronic
pain in the medical literature, there is scope to provide pri-
mary care physicians/non-pain medicine specialists with
greater understanding and awareness of pain chronification,
and to address the unmet need for a formal definition of
“pain chronification”. This article attempts to address some of
those issues. Indeed, the current lack of a universal under-
standing and formal definition of “pain chronification”
resulted in the Change Pain Chronic Advisory Board propos-
ing the following definition:
 Pain chronification describes the process of transient pain
progressing into persistent pain.
 Pain processing changes as a result of an imbalance
between pain amplification and pain inhibition.
 Genetic, environmental and biopsychosocial factors deter-
mine the risk, degree and time-course of chronification.
It is our hope that, through the proposed definition, pri-
mary care physicians and non-pain medicine specialists will
gain a broader understanding and appreciation of pain
chronification. Early intervention plays an important role in
preventing pain chronification (the transition from acute to
chronic pain) and, as key influencers in the management of
patients with acute pain, it is critical that primary care
physicians are equipped with the necessary awareness, edu-
cation and skills to manage pain patients appropriately.
There is a need for improved education and knowledge-
sharing among health care practitioners involved in the
management of pain patients, particularly primary care
physicians, including increased awareness of how and where
non-pain medicine specialists can find appropriate educa-
tion opportunities. The future development of a simple,
easy-to-use screening tool would also benefit primary care
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